• English
    • العربية
  • العربية
  • Login
  • QU
  • QU Library
  •  Home
  • Communities & Collections
View Item 
  •   Qatar University Digital Hub
  • Qatar University Institutional Repository
  • Academic
  • Student Thesis & Dissertations
  • College of Pharmacy
  • Master in Pharmacy
  • View Item
  • Qatar University Digital Hub
  • Qatar University Institutional Repository
  • Academic
  • Student Thesis & Dissertations
  • College of Pharmacy
  • Master in Pharmacy
  • View Item
  •      
  •  
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    THE ROLE OF P90 RIBOSOMAL S6 KINASE AND AUTOPHAGY IN SUNITINIB AND PONATINIB-INDUCED CARDIOTOXICITY

    Thumbnail
    View/Open
    Muna Suleiman _OGS Approved Thesis.pdf (3.878Mb)
    Date
    2019-06
    Author
    SULEIMAN, MUNA
    Metadata
    Show full item record
    Abstract
    In recent years, the paradigm cancer management has shifted towards a targeted approach. Among the newly targeted anticancer therapies are ponatinib and sunitinib, small molecules tyrosine kinase inhibitors (TKIs), used for various types of cancer. Despite their superb anticancer effects, their use has been associated with cardiovascular toxicities. Therefore, the present study aimed to investigate the cardiotoxic effects associated with ponatinib and sunitinib and to define the underlying cardiotoxic signaling pathways. In the current study, an in vitro rat cardiomyoblast (H9c2) model was used to assess the cardiotoxic effects of sunitinib and ponatinib following 6 and 24 hours. Cardiomyoblast loss was characterized by MTT assay and flow cytometer analyses. Cardiomyoblast hypertrophy was assessed by measuring H9c2 cell surface area and atrial natriuretic peptide (ANP) mRNA expression. The potential molecular mechanisms of cardiotoxicity was examined by measuring p90RSK phosphorylation and autophagic flux. Both ponatinib and sunitinib induced the highest cardiotoxic effects among the screened TKIs. Sunitinib and ponatinib treatment reduced H9c2 cardiomyoblast cell viability and induced apoptotic cell death. Sunitinib treatment induced cardiomyoblast hypertrophy, while ponatinib treatment caused cellular detachment and cellular shrinkage. In terms of molecular pathways, ponatinib treatment induced p90RSK phosphorylation and autophagy, while sunitinib treatment inhibited p90RSK activity and induced autophagy. Inhibition of p90RSK or autophagy using BID or CQ, respectively, was associated with further cellular death. Our study compared the cardiotoxicity of different clinically-approved TKIs and identified the potential mechanisms of cardiotoxicity. This study demonstrated for the first time the different cardiotoxic effects associated with ponatinib treatment in H9c2 cell line.
    DOI/handle
    http://hdl.handle.net/10576/11647
    Collections
    • Master in Pharmacy [‎62‎ items ]

    entitlement


    Qatar University Digital Hub is a digital collection operated and maintained by the Qatar University Library and supported by the ITS department

    Contact Us | Send Feedback
    Contact Us | Send Feedback | QU

     

     

    Home

    Submit your QU affiliated work

    Browse

    All of Digital Hub
      Communities & Collections Publication Date Author Title Subject Type Language Publisher
    This Collection
      Publication Date Author Title Subject Type Language Publisher

    My Account

    Login

    Statistics

    View Usage Statistics

    Qatar University Digital Hub is a digital collection operated and maintained by the Qatar University Library and supported by the ITS department

    Contact Us | Send Feedback
    Contact Us | Send Feedback | QU

     

     

    Video